Johan Iveberg is New President of Nolato Medical
By Business Wire News
By Business Wire News
Nolato AB (STO:NOLAB)
Nolato has appointed Johan Iveberg as the new President of its Nolato Medical business area and as a member of Group management. Since 2010 Johan has been the Managing Director of Nolato MediTech AB, one of the companies in this business area. He succeeds Christer Wahlquist, who became President and CEO of the Nolato Group in February.
“Following an extensive recruitment process, we have determined that Johan has the best credentials to take Nolato Medical forward,” said Christer Wahlquist.
Nolato Medical retains its growth strategy, along with its ambition to be a leading global player offering customers in the pharmaceutical and medical device sectors competitive development and production of advanced polymer products.
“Johan’s thorough knowledge of the business, as well as his many years of experience and broad network of contacts, are important elements for the business area’s ambition.”
Johan Iveberg holds an MSc in Engineering and, before joining Nolato, worked in the Trelleborg Group managing two production units. He has also held management positions at companies including Perstorp AB and Akzo Nobel AB.
Johan takes up his position as Business Area President today, 19 May. Nolato’s Group management now consists of Christer Wahlquist (President and CEO), Per-Ola Holmström (CFO), Jörgen Karlsson (President of Nolato Telecom), Johan Arvidsson (President of Nolato Industrial) and Johan Iveberg (President of Nolato Medical).
Nolato is a Swedish group with operations in Europe, Asia and North America. We develop and manufacture products in polymer materials such as plastic, silicone and TPE for leading customers within medical technology, pharmaceuticals, telecom, automotive, hygiene and other selected industrial sectors. Nolato’s shares are listed on Nasdaq Stockholm in the Mid Cap segment, where they are included in the Industrials sector.
This information is such that Nolato AB is obliged to disclose under the Swedish Securities Market Act and/or the Swedish Financial Instruments Trading Act. This information was made public on 19 May 2016 at 10:00 am.
This information was brought to you by Cision http://news.cision.com
President and CEO
+46 (0)705 804848